Rejected at 3 p.m. Oct, 31, 2023 ] by dollajas
Author: PersonaNonGrata
Related Note: 1509812729068
Rationale for change

Increase visuospatial memory for longterm storage

Rejection reason

many formatting errors

Text Text
Extra
- Pyrimethamine mechanism is via inhibition of dihydrofolate reductase

- Leucovorin is added to the treatment to avoid marrow suppression (folinic acid rescue)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid




Sketchy



Watch Toxoplasma gondii
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Systemic Protozoa: Toxoplasma>

Watch associated Bootcamp video - Antiparasitics: Pyrimethamine, Sulfadiazine, Nitroimidazoles, and Intraluminal Agents

Watch associated Bootcamp video - DNA Structure : Clinical Applications of the Pyrimidine Pathway
OME

Additional Resources
One by one
Empty field
#PANCE::EOR::PEDS #AK_Step1_v12::#AMBOSS::sbatEQ #AK_Step1_v12::^Other::^HighYield::1-HighYield !AK_UpdateTags::^temporary::ImageFix::14::done #AK_Step1_v12::#Bootcamp::Microbiology::38_Antiparasitics::01_Pyrimethamine_Sulfadiazine_Nitroimidazoles_and_Intraluminal_Agents #AK_Step2_v12::#AMBOSS::sbatEQ #AK_Step1_v12::#UWorld::Step::2082 #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::Retired_Lessons::04_HIV_&_AIDS::03_AIDS_SOAP_[OLD_VERSION] !AK_UpdateTags::Step1decks::Lolnotacop::Bugs #AK_Step1_v12::#UWorld::COMLEX::25191 #AK_Step2_v12::#B&B::08_Infectious_Disease::02_Fungi_and_Parasites::03_Protozoal_Infections #AK_Step1_v12::#Physeo::06_Micro::04_Parasites::04_Toxoplasma_Gondii #AK_Step1_v12::#Bootcamp::Microbiology::21_Systemic_Protozoa::01_Toxoplasma #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_5::Parasites::Protozoa #AK_Step1_v12::#B&B::13_Infectious_Disease::05_Parasites_and_Helminths::02_Protozoa #AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step1_v12::#SketchyMicro::04_Parasites::02_Protozoa_of_the_CNS::01_Toxoplasma_gondii #AK_Step1_v12::#Bootcamp::Genetics::01_DNA_Structure::05_Clinical_Applications_of_the_Pyrimidine_Pathway #AK_Step1_v12::#FirstAid::03_Microbiology::04_Parasitology::02_Protozoa-CNS_infections::*Toxoplasma_Gondii